Nonopioid drug for acute pain wins FDA approval

Suzetrigine, an oral drug marketed by Vertex Pharmaceuticals as Journavx, is the first to reach the market in a new class of pain treatments that avoid risks such as slowed breathing and the potential for addiction that come with opioid drugs. https://t.co/X1u75ivpAa